Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply.
Hoerauf H, Feltgen N, Weiss C, Paulus EM, Schmitz-Valckenberg S, Pielen A, Puri P, Berk H, Eter N, Wiedemann P, Lang GE, Rehak M, Wolf A, Bertelmann T, Hattenbach LO. Hoerauf H, et al. Among authors: lang ge. Am J Ophthalmol. 2016 Sep;169:292-293. doi: 10.1016/j.ajo.2016.06.016. Epub 2016 Jul 9. Am J Ophthalmol. 2016. PMID: 27401725 No abstract available.
Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study.
Hoerauf H, Feltgen N, Weiss C, Paulus EM, Schmitz-Valckenberg S, Pielen A, Puri P, Berk H, Eter N, Wiedemann P, Lang GE, Rehak M, Wolf A, Bertelmann T, Hattenbach LO; COMRADE-C Study Group. Hoerauf H, et al. Among authors: lang ge. Am J Ophthalmol. 2016 Sep;169:258-267. doi: 10.1016/j.ajo.2016.04.020. Epub 2016 May 7. Am J Ophthalmol. 2016. PMID: 27163237 Clinical Trial.
Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B).
Hattenbach LO, Feltgen N, Bertelmann T, Schmitz-Valckenberg S, Berk H, Eter N, Lang GE, Rehak M, Taylor SR, Wolf A, Weiss C, Paulus EM, Pielen A, Hoerauf H; COMRADE-B Study Group. Hattenbach LO, et al. Among authors: lang ge. Acta Ophthalmol. 2018 Feb;96(1):e10-e18. doi: 10.1111/aos.13381. Epub 2017 Mar 2. Acta Ophthalmol. 2018. PMID: 28251811 Free article. Clinical Trial.
Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study.
Feltgen N, Hattenbach LO, Bertelmann T, Callizo J, Rehak M, Wolf A, Berk H, Eter N, Lang GE, Pielen A, Schmitz-Valckenberg S, Quiering C, Rose U, Hoerauf H; COMRADE Study Group. Feltgen N, et al. Among authors: lang ge. Acta Ophthalmol. 2018 Dec;96(8):e933-e941. doi: 10.1111/aos.13770. Epub 2018 May 31. Acta Ophthalmol. 2018. PMID: 29855153 Free article. Clinical Trial.
Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion: Post-hoc Analysis from the COMRADE Trials.
Pielen A, Feltgen N, Hattenbach LO, Hoerauf H, Bertelmann T, Quiering C, Vögeler J, Priglinger S, Lang GE, Schmitz-Valckenberg S, Wolf A, Rehak M. Pielen A, et al. Among authors: lang ge. Curr Eye Res. 2020 May;45(5):604-614. doi: 10.1080/02713683.2019.1679839. Epub 2019 Oct 31. Curr Eye Res. 2020. PMID: 31665935 Clinical Trial.
[Development and validation of novel clinical endpoints in intermediate age-related macular degeneration in MACUSTAR].
Terheyden JH, Finger RP, Schmitz-Valckenberg S, Agostini H, Dahlke C, Kuehlewein L, Lang GE, Pauleikhoff D, Wolf A, Boettger MK, Luhmann UFO, Asmus F, Holz FG; MACUSTAR-Konsortium. Terheyden JH, et al. Among authors: lang ge. Ophthalmologe. 2019 Dec;116(12):1186-1193. doi: 10.1007/s00347-019-0907-1. Ophthalmologe. 2019. PMID: 31087116 Review. German.
[Successful Systemic Lysis Therapy in Acute Retinal Arterial Occlusions].
Raber FP, Reinking K, Schmitz-Valckenberg S, Althaus K, Kaut O, Witry M, Lang GE. Raber FP, et al. Among authors: lang ge. Klin Monbl Augenheilkd. 2020 Jun;237(6):772-779. doi: 10.1055/a-1079-5635. Epub 2020 Feb 24. Klin Monbl Augenheilkd. 2020. PMID: 32092776 German.
245 results